NEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday:
GameStop Corp., down 47 cents to $9.63
The video game retailer's first-quarter profit and revenue fell short of analysts' expectations and it gave investors a weak forecast.
Dave & Buster's Entertainment Inc., up $2.47 to $52.95
The restaurant and arcade chain's fourth-quarter profit and a key sales measure blew past Wall Street expectations.
Advanced Micro Devices Inc., up $2.27 to $29.02
The chipmaker and its rivals gained on media reports that orders for smartphone chips are higher so far this quarter.
Intel Corp., up $1.12 to $55.48
The chipmaker named George Davis its new chief financial officer, after hiring him away from rival Qualcomm.
Blue Apron Holdings Inc., up 7 cents to $1.04
The meal-kit seller's CEO is resigning and will be replaced by a former Etsy Inc. executive.
Nektar Therapeutics Inc., up $1.59 to $35.29
The biotechnology company presented a series of positive early studies for potential cancer treatments.
Acuity Brands Inc., up $10.90 to $134.79
The lighting maker beat Wall Street's profit forecasts for the fiscal second quarter.
USANA Health Sciences Inc., down $2.90 to $81.25
The nutritional supplements company expects a drop in sales during the first quarter, citing a lack of promotional activity.
Before you consider Nektar Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nektar Therapeutics wasn't on the list.
While Nektar Therapeutics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
